These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28921919)

  • 1. Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.
    Ma RC; Del Prato S; Gallwitz B; Shivane VK; Lewis-D'Agostino D; Bailes Z; Patel S; Lee J; von Eynatten M; Di Domenico M; Ross SA
    J Diabetes Investig; 2017 Sep; 9(3):579-86. PubMed ID: 28921919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial.
    Ross SA; Caballero AE; Del Prato S; Gallwitz B; Lewis-D'Agostino D; Bailes Z; Thiemann S; Patel S; Woerle HJ; von Eynatten M
    Diabetes Obes Metab; 2015 Feb; 17(2):136-44. PubMed ID: 25298165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia.
    Ross SA; Caballero AE; Del Prato S; Gallwitz B; Lewis-D'Agostino D; Bailes Z; Thiemann S; Patel S; Woerle HJ; von Eynatten M
    Postgrad Med; 2016 Nov; 128(8):747-754. PubMed ID: 27684308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of linagliptin in Asian patients with type 2 diabetes mellitus inadequately controlled by metformin: A multinational 24-week, randomized clinical trial.
    Wang W; Yang J; Yang G; Gong Y; Patel S; Zhang C; Izumoto T; Ning G
    J Diabetes; 2016 Mar; 8(2):229-37. PubMed ID: 25753488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18-week randomized, double-blind, placebo-controlled phase III trial with a 34-week active-controlled extension.
    Barnett AH; Patel S; Harper R; Toorawa R; Thiemann S; von Eynatten M; Woerle HJ
    Diabetes Obes Metab; 2012 Dec; 14(12):1145-54. PubMed ID: 22974280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials.
    Lv Q; Shen J; Miao L; Ye B; Schepers C; Plat A; Shi Y
    Diabetes Ther; 2020 Jun; 11(6):1317-1330. PubMed ID: 32328953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes.
    Mu Y; Pan C; Fan B; Hehnke U; Zhang X; Zhang X; Wang X; Liu J; Zhang Y; Du J; Ma J; Gong Y
    Diabetes Res Clin Pract; 2017 Feb; 124():48-56. PubMed ID: 28088030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of linagliptin in elderly patients with type 2 diabetes: a pooled analysis of eight placebo-controlled clinical trials].
    Guo XH; Feng ZK; Xu LH
    Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):588-594. PubMed ID: 28789492
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trials.
    Del Prato S; Taskinen MR; Owens DR; von Eynatten M; Emser A; Gong Y; Chiavetta S; Patel S; Woerle HJ
    J Diabetes Complications; 2013; 27(3):274-9. PubMed ID: 23403068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of linagliptin monotherapy in Asian patients with inadequately controlled type 2 diabetes mellitus: A multinational, 24-week, randomized, clinical trial.
    Chen Y; Ning G; Wang C; Gong Y; Patel S; Zhang C; Izumoto T; Woerle HJ; Wang W
    J Diabetes Investig; 2015 Nov; 6(6):692-8. PubMed ID: 26543544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis.
    Wu D; Li L; Liu C
    Diabetes Obes Metab; 2014 Jan; 16(1):30-7. PubMed ID: 23803146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia.
    Haak T
    Adv Ther; 2012 Dec; 29(12):1005-15. PubMed ID: 23212658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.
    Bajaj M; Gilman R; Patel S; Kempthorne-Rawson J; Lewis-D'Agostino D; Woerle HJ
    Diabet Med; 2014 Dec; 31(12):1505-14. PubMed ID: 24824197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of linagliptin in subjects with long-standing type 2 diabetes mellitus (>10 years): evidence from pooled data of randomized, double-blind, placebo-controlled, phase III trials.
    Lajara R; Aguilar R; Hehnke U; Woerle HJ; von Eynatten M
    Clin Ther; 2014 Nov; 36(11):1595-605. PubMed ID: 25236917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled study.
    Haak T; Meinicke T; Jones R; Weber S; von Eynatten M; Woerle HJ
    Diabetes Obes Metab; 2012 Jun; 14(6):565-74. PubMed ID: 22356132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of initial combination of linagliptin and metformin in patients with type 2 diabetes: A subgroup analysis of Indian patients from a randomized, double-blind, placebo-controlled study.
    Deshmukh V; Sathyanarayana S; Menon S; Patil S; Jones R; Uppal S; Siddiqui K
    Indian J Endocrinol Metab; 2015; 19(2):256-61. PubMed ID: 25729688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin.
    Freeman JS
    Drugs Context; 2013 Aug; 2013():212256. PubMed ID: 24432043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of linagliptin as monotherapy or add-on treatment in Asian patients with suboptimal glycemic control: a pooled analysis.
    Zeng Z; Choi DS; Mohan V; Emser A; Siddiqui K; Gong Y; Patel S; Woerle HJ
    Curr Med Res Opin; 2015 Jan; 31(1):99-106. PubMed ID: 25215428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial.
    Barnett AH; Huisman H; Jones R; von Eynatten M; Patel S; Woerle HJ
    Lancet; 2013 Oct; 382(9902):1413-23. PubMed ID: 23948125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus.
    Sheu WH; Park SW; Gong Y; Pinnetti S; Bhattacharya S; Patel S; Seck T; Woerle HJ
    Curr Med Res Opin; 2015 Mar; 31(3):503-12. PubMed ID: 25629790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.